144 related articles for article (PubMed ID: 26867023)
1. Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea.
Weinstock LB; Myers TL; Walters AS; Schwartz OA; Younger JW; Chopra PJ; Guarino AH
A A Case Rep; 2016 May; 6(9):272-6. PubMed ID: 26867023
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN).
Chopra P; Cooper MS
J Neuroimmune Pharmacol; 2013 Jun; 8(3):470-6. PubMed ID: 23546884
[TBL] [Abstract][Full Text] [Related]
3. The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up.
Drago F; De Col E; Agnoletti AF; Schiavetti I; Savarino V; Rebora A; Paolino S; Cozzani E; Parodi A
J Am Acad Dermatol; 2016 Sep; 75(3):e113-e115. PubMed ID: 27543234
[No Abstract] [Full Text] [Related]
4. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin.
Weinstock LB; Steinhoff M
J Am Acad Dermatol; 2013 May; 68(5):875-6. PubMed ID: 23602178
[No Abstract] [Full Text] [Related]
5. Severity and specificity of neglect-like symptoms in patients with complex regional pain syndrome (CRPS) compared to chronic limb pain of other origins.
Frettlöh J; Hüppe M; Maier C
Pain; 2006 Sep; 124(1-2):184-9. PubMed ID: 16730904
[TBL] [Abstract][Full Text] [Related]
6. Complex regional pain syndrome-like symptoms during herpes zoster.
Berry JD; Rowbotham MC; Petersen KL
Pain; 2004 Jul; 110(1-2):e1-12. PubMed ID: 15275746
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study.
Kiefer RT; Rohr P; Ploppa A; Dieterich HJ; Grothusen J; Koffler S; Altemeyer KH; Unertl K; Schwartzman RJ
Pain Med; 2008 Nov; 9(8):1173-201. PubMed ID: 18266808
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic approach to complex regional pain syndrome: light and shade.
Casale R; Atzeni F; Sarzi-Puttini P
Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S126-39. PubMed ID: 25786054
[TBL] [Abstract][Full Text] [Related]
9. Smoking interacts with sleep apnea to increase cardiovascular risk.
Lavie L; Lavie P
Sleep Med; 2008 Mar; 9(3):247-53. PubMed ID: 17513169
[TBL] [Abstract][Full Text] [Related]
10. Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNF-α chimeric monoclonal antibody infliximab in complex regional pain syndrome.
Dirckx M; Groeneweg G; Wesseldijk F; Stronks DL; Huygen FJ
Pain Pract; 2013 Nov; 13(8):633-40. PubMed ID: 23692303
[TBL] [Abstract][Full Text] [Related]
11. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
Cuoco L; Salvagnini M
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):89-95. PubMed ID: 16554709
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of rifaximine in small intestinal bacterial overgrowth syndrome in patients after cholecystectomy].
Mechetina TA; Il'chenko AA
Ter Arkh; 2011; 83(12):68-73. PubMed ID: 22416449
[TBL] [Abstract][Full Text] [Related]
13. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL
Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626
[TBL] [Abstract][Full Text] [Related]
14. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
[TBL] [Abstract][Full Text] [Related]
15. The Treatment of Longstanding Complex Regional Pain Syndrome with Oral Steroids.
Barbalinardo S; Loer SA; Goebel A; Perez RS
Pain Med; 2016 Feb; 17(2):337-43. PubMed ID: 26814238
[TBL] [Abstract][Full Text] [Related]
16. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome.
Goebel A; Buhner S; Schedel R; Lochs H; Sprotte G
Rheumatology (Oxford); 2008 Aug; 47(8):1223-7. PubMed ID: 18540025
[TBL] [Abstract][Full Text] [Related]
17. Objective sensory evaluation of the spread of complex regional pain syndrome.
Edinger L; Schwartzman RJ; Ahmad A; Erwin K; Alexander GM
Pain Physician; 2013; 16(6):581-91. PubMed ID: 24284843
[TBL] [Abstract][Full Text] [Related]
18. Intravenous regional ketorolac and lidocaine in the treatment of complex regional pain syndrome of the lower extremity: a randomized, double-blinded, crossover study.
Eckmann MS; Ramamurthy S; Griffin JG
Clin J Pain; 2011; 27(3):203-6. PubMed ID: 21358290
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
Safarpour D; Jabbari B
Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
[TBL] [Abstract][Full Text] [Related]
20. Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome).
Santamato A; Ranieri M; Panza F; Solfrizzi V; Frisardi V; Stolfa I; Megna M; Fiore P
Pain Med; 2009 Jan; 10(1):179-85. PubMed ID: 19222778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
